Genetic influences on aspirin response in patients undergoing percutaneous coronary intervention

Cardiovasc Res. 2019 Aug 1;115(10):1452-1453. doi: 10.1093/cvr/cvz110.

Authors

Kevin A Friede¹, Deepak Voora^{1

2}

Affiliations

¹ Division of Cardiology, Duke University, Duke University Medical Center, 2301 Erwin Road, Durham, NC, USA.
² Center for Applied Genomics & Precision Medicine, Duke University, 101 Science DriveBox #3382, CIEMAS Building, Duke University Medical Center, Durham, NC, USA.

No abstract available

Publication types

Comment

MeSH terms

Aspirin
Coronary Artery Disease*
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors
Soluble Guanylyl Cyclase

Substances

GUCY1A1 protein, human
Platelet Aggregation Inhibitors
Soluble Guanylyl Cyclase
Aspirin

Grants and funding

T32 HL007101/HL/NHLBI NIH HHS/United States